DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Baghdasaryan A, Claudel T, Gumhold J. , et al.
Dual farnesoid X receptor/TGR5 agonist INT-767 reduces liver injury in the Mdr2-/- (Abcb4-/-) mouse cholangiopathy model by promoting biliary HCO−3 output.
Hepatology 2011;
54 (04) 1303-1312
We do not assume any responsibility for the contents of the web pages of other providers.